InnovateAI secures $50M Series B for AI diagnostic tool MediPredict
Healthcare AI startup raises $50M, already deployed in 50+ hospitals.
InnovateAI, a healthcare-focused AI startup founded in 2020, has secured $50 million in Series B funding led by TechVentures Capital, with participation from HealthTech Partners and existing investor Alpha Investments. The round will accelerate development and market expansion of MediPredict, a new AI-powered diagnostic tool designed to provide early and accurate disease detection. According to CEO Dr. Anya Sharma, the funding validates the team’s work and the potential of MediPredict to improve patient outcomes while reducing healthcare costs. The company plans to grow its engineering and data science teams and expand its presence across North America and Europe.
MediPredict builds on InnovateAI’s existing product, DataHealth, which is already deployed in over 50 hospitals globally. TechVentures Capital Managing Partner David Chen highlighted InnovateAI’s robust technology and clear market path, noting the company’s commitment to ethical, patient-centric AI. The $50M injection positions InnovateAI to scale its predictive analytics solutions more broadly, targeting both early detection and cost efficiency in healthcare. The company aims to leverage advanced AI to make healthcare more accessible, efficient, and effective for providers and patients alike.
- InnovateAI raised $50M in Series B led by TechVentures Capital, with HealthTech Partners and Alpha Investments participating.
- MediPredict is an AI diagnostic tool focused on early and accurate disease detection to improve outcomes and cut costs.
- The company’s existing product, DataHealth, is already deployed in over 50 hospitals across the globe.
Why It Matters
AI-driven early disease detection could cut healthcare costs and save lives at scale.